Yifeng Pharmacy Chain Co., Ltd. (SHA:603939)
China flag China · Delayed Price · Currency is CNY
22.22
-0.09 (-0.40%)
May 8, 2026, 3:00 PM CST

Yifeng Pharmacy Chain Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
26,93926,33329,25640,46446,07439,611
Market Cap Growth
-15.52%-9.99%-27.70%-12.18%16.31%-17.30%
Enterprise Value
22,64823,62927,39640,07646,95440,304
Last Close Price
22.2221.7223.4631.7335.8330.75
PE Ratio
15.8715.6919.1428.6636.5144.61
Forward PE
14.0214.1118.0425.1436.9034.54
PS Ratio
1.101.081.221.792.322.59
PB Ratio
2.092.132.573.875.055.04
P/TBV Ratio
3.914.125.358.5711.8511.74
P/FCF Ratio
8.938.688.2710.4213.8229.95
P/OCF Ratio
8.167.846.938.7511.7518.42
EV/Sales Ratio
0.920.971.141.772.362.63
EV/EBITDA Ratio
5.428.9010.9817.9622.2126.49
EV/EBIT Ratio
9.219.8812.3219.9124.3629.26
EV/FCF Ratio
7.517.787.7410.3214.0930.48
Debt / Equity Ratio
0.330.360.460.360.380.42
Debt / EBITDA Ratio
1.021.071.291.041.031.29
Debt / FCF Ratio
1.421.451.490.981.042.52
Net Debt / Equity Ratio
-0.39-0.38-0.24-0.13-0.080.03
Net Debt / EBITDA Ratio
-1.87-1.77-1.09-0.63-0.330.17
Net Debt / FCF Ratio
-1.68-1.55-0.77-0.36-0.210.19
Asset Turnover
0.900.880.921.001.040.95
Inventory Turnover
3.483.263.483.783.633.52
Quick Ratio
1.090.990.840.690.670.67
Current Ratio
1.541.431.261.081.101.17
Return on Equity (ROE)
15.18%15.40%15.14%16.16%16.76%14.65%
Return on Assets (ROA)
5.63%5.39%5.33%5.57%6.33%5.32%
Return on Invested Capital (ROIC)
23.56%21.81%19.01%17.88%17.68%13.97%
Return on Capital Employed (ROCE)
15.20%15.20%14.50%15.60%16.90%13.40%
Earnings Yield
6.42%6.37%5.22%3.49%2.74%2.24%
FCF Yield
11.20%11.53%12.10%9.60%7.23%3.34%
Dividend Yield
3.14%3.22%2.77%1.31%0.66%0.58%
Payout Ratio
49.65%50.60%55.38%22.80%18.63%23.86%
Buyback Yield / Dilution
0.20%-0.12%-2.15%0.37%-0.70%-4.01%
Total Shareholder Return
3.26%3.10%0.63%1.69%-0.03%-3.43%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.